SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017676
Filing Date
2024-06-20
Accepted
2024-06-20 16:46:36
Documents
2
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 form4-06202024_080632.html 4  
1 form4-06202024_080632.xml 4 4115
2 ex24-06202024_080635.htm EX-24 6591
  Complete submission text file 0001415889-24-017676.txt   12267
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O UNITEDHEALTH GROUP INCORPORATED 9900 BREN ROAD EAST MINNETONKA MN 55123
Business Address
Tuckson Reed Vaughn (Reporting) CIK: 0001511051 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 241057154